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Columnar cell lesions of the breast are increasingly recognized at mammography for their tendency to calcify.
We studied 392 vacuum-assisted core biopsies performed solely for calcifications to evaluate the frequency of
columnar cell lesions, their relationship with radiological risk, appearance of calcifications, and clinical data.
Management and follow-up of columnar cell lesions without and with atypia (flat epithelial atypia) was analyzed.
Cases with architectural atypia (cribriform spaces and/or micropapillae) were excluded from flat epithelial
atypia. Calcifications were within the lumen of acini affected by columnar cell lesions in 137 out of 156 biopsies
diagnosed with some columnar cell lesions. These represented 37% of vacuum-assisted core biopsies and 62%
of low radiological risk (BI-RADS3) calcifications. High-risk (BI-RADS5) calcifications were never associated
with columnar cell lesions. Age and menopausal status were comparable in columnar and in not-columnar cell
lesions. Atypia was associated with long-term hormone replacement therapy in both lesions. Surgical
biopsy was recommended for all cases with atypia. Flat epithelial atypia, as the only histological findings on
vacuum-assisted core biopsies, was never associated with malignancy at surgery. In conclusion, we suggest
that surgical excision is not mandatory when flat epithelial atypia is found as the most advanced lesion on
vacuum-assisted core biopsy performed for low radiological risk calcifications, and that women should be
advised of the possible hormone dependency of this entity.
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Stereotactic vacuum-assisted core biopsy is cur-
rently used to diagnose indeterminate or suspicious
breast calcifications that are histologically related to
a spectrum of breast lesions encompassing ductal
carcinomas in situ and preneoplastic and benign
lesions. Often this type of calcification resides in
so-called ‘columnar cell lesions’,1 entities character-
ized by the presence of columnar epithelial cells
lining the terminal duct lobular units that typically
show flocculant or secretory material and micro-
calcifications in the lumen. The Breast Imaging
Reporting and Data System (BI-RADS)2 has standar-
dized the description and management of findings
identified on mammograms, thereby facilitating
communication between radiologists and referring
physicians. However, to our knowledge, there are no
specific studies evaluating whether specific calcifi-
cation descriptors are associate with columnar cell
lesions.
Columnar cell lesions have been described under
a variety of names.3–7 According to Schnitt and
Vincent-Salomon,1 columnar cell lesions have been
grouped into the categories of columnar cell change
and columnar cell hyperplasia without or with
atypia. Other authors8 have proposed a subcategori-
zation of columnar cell lesions depending on the
presence of architectural and/or cytological atypia.
The unifying term ‘flat epithelial atypia’ has
been proposed by the World Health Organization
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Working Group on the Pathology and Genetics of
Tumors of the Breast9 for columnar cell lesions with
low-grade cytological atypia.
From a biological point of view, columnar
cell lesions are low-grade proliferating lesions
that invariably express estrogen receptors.10
A recent experimental study indicates that colum-
nar cell lesions exhibit a hyperresponsive pheno-
type in the presence of estrogen and atypical
proliferation, leading to flat epithelial atypia, may
be promoted by exogenous 17b-estradiol exposure.11
On the other hand, it has been shown that the
columnar cell lesions frequently coexist with and
show the same genetic alterations of hormone-
dependent lesions, such as low-grade ductal
carcinoma in situ (particularly, micropapillary and
cribriform type), lobular intraepithelial neoplasia,
and invasive tubular carcinoma.8,12,13 All these data
may be considered for postmenopausal women with
a history of columnar cell lesions who are currently
receiving or considering for hormone replacement
therapy. Moreover, several experts in breast patho-
logy underline that there is an urgent need for large,
comprehensive studies describing more accurately
the risk of finding malignant diseases after a
diagnosis of columnar cell lesions on core biopsy
specimens.14,15
Taking all these data together, the aims of our
study were the following: (1) to evaluate the
frequency of columnar cell lesions in the routine
diagnosis of a series of vacuum-assisted core
biopsies carried out for radiological calcifications;
(2) to correlate the patient’s clinical data (age and
use of hormone replacement therapy) with the
histological findings; (3) to evaluate whether
specific calcification descriptors and BI-RADS
categories correlate with columnar cell lesions; and
(4) to define the management of patients, throughout
the analysis of clinical and surgical follow-up.
Materials and methods
Patients
From January 2004 to June 2006, 421 image-guided
stereotactic vacuum-assisted core biopsies were
performed in 418 women. To ensure accurate
characterization of the calcifications and appropri-
ate correlation with histology and follow-up, we
restricted the study to 392 women with calcifica-
tions as the only mammographic lesion while
excluded 26 women carrying calcifications asso-
ciated with opacities, structural thickening, or
architectural distortion. Patients were divided into
two groups, 156 with a diagnosis of columnar cell
lesions with or without atypia, either pure or
associated with other lesions, and 236 with lesions
not associated with columnar cells (not-columnar
cell lesions). The age and the use of hormone
replacement therapy were considered in the two
groups.
Radiological Data
The selection of lesions to be submitted to stereotactic
vacuum-assisted core biopsy was not fully centralized
but also requested by outside institutions to our
center. Mammograms of women sent to our center for
vacuum-assisted core biopsy were reviewed and
reclassified. The ideal radiological risk for this biopsy
procedure was BI-RADS category 4. Vacuum-assisted
core biopsy was also performed for patients with
likely benign BI-RADS category 3 calcifications that
could not be traced back on previous mammograms or
were present in addition to an already known
calcification or cluster. BI-RADS category 5 (highly
suggestive of malignancy) was sampled only in cases
in which fine needle aspiration biopsy had an
inconsistent response. Vacuum-assisted core biopsy
was performed under stereotactic guidance using the
Fischer Mammotest prone table (Fischer Imaging,
Denver, CO, USA) in combination with the Mammo-
tome (Ethicon Endo-Surgery, Cincinnati, OH, USA)
probe device mounting the 11-gauge needle. The
number of core tissue specimens per case ranges from
6 to 18 and radiography of the specimens was
performed in each case to verify the presence of the
calcifications. Two radiologists (GM and PPC) experi-
enced in breast imaging and blinded to the histolo-
gical diagnosis reviewed and established a consensus
on all mammograms.
Histological Data
The cores with and without calcifications on speci-
men radiograms were separately submitted for
pathological examination. Four sections were routi-
nely cut, and additional sections were examined if
needed.
For the study purposes, each case was reviewed
by dedicated breast pathologists (AS and LM)
blinded to the radiological data. The location of
calcifications within or outside columnar cell
lesions was also recorded to further assess the
correspondence between the radiological calcifica-
tions and histological findings.
To simplify the histological classification of
columnar cell lesions, we diagnosed columnar cell
change and columnar cell hyperplasia without
atypia as ‘columnar cell lesions without atypia’
whereas those with atypia as flat epithelial atypia.
Following recent suggestions,14,15 we included in
the flat epithelial atypia only lesions exhibiting
monomorphic flat proliferation of atypical cells
within the terminal duct lobular units with a slight
loss of polarity or stratified nuclei. Lesions with
complex architectural patterns such as cribriform
spaces or micropapillae, according to the extent and
degree of these, were placed within the atypical
ductal hyperplasia or low-grade ductal in situ
carcinoma. According to the European Guideline
for breast screening pathology,16 samples with
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benign lesions but without calcifications on the core
biopsy specimens were classified as inadequate B1;
columnar cell lesions without atypia as B2; flat
epithelial atypia and columnar cell lesions without
atypia associated with lobular intraepithelial neo-
plasia or atypical ductal hyperplasia or papillomas
as B3; and any columnar cell lesions associated with
carcinoma in situ or invasive carcinoma were
classified as B5a or B5b, respectively. We decided
to classify flat epithelial atypia involving more than
four vacuum-assisted core biopsy samples as B4.
Patient Management
To define the management of patients, the radiolo-
gist, the pathologist, and the surgeon routinely
discussed all cases at multidisciplinary meetings.
For benign lesions, classified as B2, imaging follow-
up was suggested within 12 months as it is
recommended in mammographic practice audits.2
Patients with atypical lesions B3 were discussed
and recommended for surgery or radiological fol-
low-up within 12 months depending on the pre-
sence or absence of residual calcifications on post-
vacuum-assisted core biopsy radiograms and on the
type of lesions associated with columnar cells. B4
and B5 lesions were sent to surgical excision.
Pathological findings at the patient’s definitive
surgical intervention served as the reference
standard for atypical or malignant lesions.
Statistical Analysis
Statistical analysis was performed using the two-
tailed Fisher’s exact test with Bonferroni correction.
Statistical significance was defined as Po0.05. The
analysis was performed using R, statistical software
that is freely available from the Internet (http://
cran.r-project.org/).
Results
Localization of Calcifications in Columnar Cell
Lesions
First of all, to ensure that columnar cell lesions were
not associated by mere chance to the calcifications
target of the vacuum-assisted core biopsy, we
assessed the histological location of the calcifica-
tions in 156 cases diagnosed with columnar cell
lesions either as the main lesion or associated with
other pathological entities. Nineteen cases showing
only stromal calcium deposits or luminal calcifica-
tions not within columnar cell lesions were
excluded. Out of the 156 cases, 137 (88%) showed
granular or laminar calcifications featuring psam-
momatous bodies or calcified amorphous intralum-
inal secretions within the lumen (Figure 1).
In particular, in 3 cases of the B5 category,
calcifications were present in columnar cell lesions
only and absent in the associated malignancy and in
11 cases the same type of calcifications were
histologically located within both columnar cell
lesions and ductal carcinoma in situ. One case
showing calcifications only in ductal carcinoma
in situ was excluded from the analysis.
Clinical Data
The final cohort, excluding the 19 cases with
calcifications outside the lumen of columnar cell
Figure 1 Hematoxylin and eosin stained sections of stereotactic vacuum-assisted core biopsy performed on radiological calcifications
described in Figure 2. Low power magnification of specimens. Calcifications are present in samples 1 and 2 (a). Higher magnification
(10) of sample 1 shows that in the same columnar cell lesions are calcified amorphous intraluminal secretions, psammomatous bodies,
and granular calcifications (b). The epithelium shows cellular stratification, low-grade cytologic atypia and apical cytoplasmic snouts
typical of flat epithelial atypia (B3) (40) (c).
Correlations of columnar cell lesions on VACB
R Senetta et al
764
Modern Pathology (2009) 22, 762–769
lesions, was of 373 women. Columnar cells with
luminar calcifications represented the target of
37% of stereotactic vacuum-assisted core biopsy
(Table 1). Of the 373 women, 209 were enrolled from
screening programs and 264 were referred by their
physician or sent to our institution from other
radiology centers. The proportion of columnar cell
lesions was comparable in screening and nonscre-
ening patients. The mean ages of women with
columnar and not-columnar cell lesions were 53.9
(range 36–71 years) and 57.2 years (range 40–80
years), respectively.
The correlation with hormone replacement
therapy was evaluated only in the screening
patients, because these data were not available for
all of the patients in the nonscreening series
(Table 1). In this subset, the proportion of hormone
replacement treatment was comparable in columnar
and not-columnar cell lesions. No differences were
observed between the number of atypical and
nonatypical lesions in the two groups. However,
patients carrying atypical lesions in both groups
were exposed to hormone replacement therapy for a
longer time (median exposure time in atypical
lesions 5 years vs 2 years in benign lesions).
Radiological Risk (BI-RADS), Morphology, and
Distribution of Radiological Calcifications
Statistically significant differences (Po0.001) were
observed in the BI-RADS categories between the
calcifications related and unrelated to columnar cell
lesions. BI-RADS3 was due to columnar cell lesions
in about two-third of the cases (Table 2) and in
particular atypia was encountered in 20% of these
cases (14 B3 out of 71 BI-RADS3). In contrast, only
three cases of BI-RADS3 in the not-columnar cell
lesions were related to atypical B3 lesions and
the remaining cases were benign. Approximately
two-third of BI-RADS4 and the few cases of
BI-RADS5 submitted to vacuum-assisted core biopsy
were due to not-columnar cell lesions (Table 2).
On the contrary, no statistically significant
differences (P¼ 0.08) in morphological patterns
were observed between calcifications associated
and unassociated with columnar cells (Table 3).
However, none of the columnar cell lesions per se
was associated with linear or branching calcifica-
tions (P¼ 0.02).
In columnar cell lesions, calcifications were
clustered with a lobular distribution (Figures 2a
and b) and with an extensiono1 cm. In 10 cases one
to three clusters of calcifications were present in one
quadrant. In these cases vacuum-assisted core
biopsy was performed either on the cluster with
higher radiological risk or on a single cluster if they
showed the same risk.
Histological Category (B)
Columnar cell lesions represented the major source
of the B3 histological category (60 vs 40%) (Table 4),
whereas the B2 and B4/B5 were mainly the result of
not-columnar cell lesions (P50.001).
Treatment and Follow-Up
Patients with columnar cell lesions without atypia
(B2) were recommended for follow-up, except for
Table 1 Clinical features according to the diagnosis of columnar
cell lesions or not-columnar cell lesions on stereotactic vacuum-
assisted core biopsies
CCLs (%) Not-CCLs (%)
Total 137/373 (37) 236/373 (63)
Screen-detected 79 (38) 130 (62)
Not screen-detected 58 (35) 106 (64)
Age at VACB (years)
o40 2 (1) 0 (0)
40–49 22 (16) 27 (11)
50–59 83 (60) 131 (55)
60–69 27 (20) 63 (27)
470 3 (2) 15 (6)
HRT in 209 women of screening program
Yes 14 (18) 18 (14)
No 65 (82) 112 (86)
CCLs: columnar cell lesions; HRT: hormone replacement therapy;
VACB: vacuum-assisted core biopsy.
Table 3 Correlations of radiological morphology of calcifications







Amorphous/indistinct 161 (43) 59 (37) 102 (63)
Fine pleomorphica 95 (25) 40 (42) 55 (58)
Linear or branching 9 (2) 0 (0) 9 (100)




Round, powdery, large rodlike, and heterogeneous calcifications.
CCL: columnar cell lesions.
Table 2 Correlations of histological diagnosis (columnar cell








BI-RADS3 71 (19) 44 (62) 27 (38)
BI-RADS4 294 (79) 93 (32) 201 (68)
BI-RADS5 8 (2) 0 (0) 8 (100)
P50.001
CCLs: columnar cell lesions.
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five patients who underwent surgery because the
area of calcifications exceeded 1 cm and could not
be completely harvested by vacuum-assisted core
biopsy (Table 5). The benign nature of all of these
lesions was confirmed at definitive surgery. Follow-
ing the European Guideline,16 surgical biopsy was
recommended for all B3 cases, with the exception of
one woman, with columnar cell lesions without
atypia associated with a benign papilloma, who was
recommended for follow-up because all calcifica-
tions were harvested during the biopsy procedure.
Nine women with B3 lesions refused surgical
excision. All of them were either free of disease or
yielded unmodified radiograms at the mammo-
graphic follow-up (Table 5). Of the 41 patients with
flat epithelial atypia (both B3 and B4) as the only
histological finding on biopsy specimens, 36 under-
went surgery. In 20 cases calcifications were still
present on radiograms of the surgical specimens.
Histological atypia was confirmed in 53% of flat
epithelial atypia of the B3 category and in 2 out of 3
cases classified as B4. Specifically, atypical ductal
hyperplasia (13%), lobular intraepithelial neoplasia
(23%), and flat epithelial atypia (34%), either as a
single lesion or in association with the others, were
still present on the surgical specimen. Benign
papillomas were also present in 13 (38%) of these
cases. We recommended surgery for the 13 cases of
columnar cell lesions without atypia or flat epithe-
lial atypia associated with atypical ductal hyperpla-
sia or lobular intraepithelial neoplasia (5 LIN1 and 6
LIN2). In one case associated with atypical ductal
hyperplasia and in five cases associated with lobular
intraepithelial neoplasia on core biopsy, residual
lobular neoplastic foci not associated with calcifica-
tions were present in the surgical specimens. One
case of columnar cell lesions without atypia asso-
ciated with lobular intraepithelial neoplasia (LIN2)
was upgraded to ductal carcinoma in situ and foci of
lobular intraepithelial neoplasia of the same type
were still present.
All patients with lesions in the B5 category
underwent surgery. Malignancy was confirmed on
the surgical specimen in 12 out of 13 cases. In one
case, the low-grade ductal carcinoma in situ was
completely removed by vacuum-assisted core
biopsy (16 cores) and foci of lobular intraepithelial
neoplasia were present in the final surgical samples.
In two cases, the definitive histology was upgraded
from ductal carcinoma in situ to well-differentiated
invasive ductal carcinoma and to tubular carcinoma,
respectively. Residual invasive ductal carcinoma,
ductal carcinoma in situ, and atypical ductal
hyperplasia were found in the surgical specimen
of the single case of columnar cell lesions without
atypia that was associated with invasion on
vacuum-assisted core biopsy.
Discussion
Columnar cell lesion is one of the most common
abnormalities in the adult breast.17,18 Assessment of
the radiological and clinical significance of the
Figure 2 (a) Digital radiogram of Fischer Mammotest of BI-RADS3 clustered calcifications, 7 mm in the largest diameter, with indistinct
morphology. (b) Radiogram of vacuum-assisted core biopsy specimens: clusters of calcifications are present on specimens 1 and 2.
Table 4 Correlations of histological diagnosis (columnar vs not-










B1 6 (2) 0 (0) 6 (100)
B2 207 (55) 68 (33) 139 (67)
B3 86 (23) 52 (60) 34 (40)
B4 8 (2) 3 (37) 5 (62)
B5a 53 (14) 13 (24) 40 (75)
B5b 13 (3) 1(8) 12 (92)
P50.001
CCLs: columnar cell lesions.
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columnar cell lesions has been hampered by varia-
tions in the terminology used to describe these
histological entities and by the limited number of
cases that have been studied in a systematic fashion
in the presurgical setting. This is the first study
correlating columnar cell lesions and radiological
calcifications on a series of 392 consecutive stereo-
tactic vacuum-assisted core biopsies. Taking into
account the actual histological location of calcifica-
tions associated with a diagnosis of columnar cell
lesions, we showed that these lesions represent the
background of about 37% of the radiological
calcifications, a percentage slightly lower than that
previously reported.3 The radiological shape of
these calcifications cannot be used to absolutely
differentiate columnar from not-columnar cell le-
sions, although linear or branching calcifications are
never found within columnar cell lesions per se.
Instead, the clustered amorphous/indistinct or gran-
ular radiological morphology of calcifications may
be explained by considering that columnar cell
lesions develop in multiple terminal duct lobular
units with calcium deposits inside the lumen
containing secretory material.1 Over time, these
deposits become tighter, with a laminar concentric
appearance and give rise to histological psammo-
matous calcifications, typical of both benign and
malignant lesions.19 On the other hand, considering
the radiological risk category, we showed that
columnar cell lesions are the major source of BI-
RADS3, but this low risk may be associated with
histological atypia in about 20% of the cases,
whereas calcifications with the same radiological
risk are rarely associated with atypia in the not-
columnar cell lesions. In addition, the follow-up
study showed that classifying flat epithelial atypia
involving more than four cores as B4 is rather
arbitral, because none of the three cases of our series
showed malignancy on the surgical samples.
The appropriate pathology work-up and clinical
management of patients, whose presurgical speci-
mens show columnar cell lesions, are evolving as
information regarding these lesions begins to accu-
mulate. First of all, morphological criteria to
differentiate flat epithelial atypia from other types
of intraepithelial proliferating lesions such as
atypical ductal hyperplasia are now established.14,15
However, columnar cell lesions may be associated
with other preneoplastic or neoplastic entities. The
prevalence of atypical ductal hyperplasia associated
with columnar cell lesions in vacuum-assisted core
biopsies in the present series is quite low, but on the
final surgical specimens, we confirmed that atypical
ductal hyperplasia and lobular intraepithelial neo-
plasia were the most common accompanying le-
sions.20–22 In addition, our results show that small
papillomas/papillomatosis of terminal duct lobular
unit are often related to columnar cell lesions as
well. In a recent study on a small series of core
biopsies not-vacuum-assisted,23 it has been shown
that flat epithelial atypia was associated with
malignancy in 2 out of 11 cases. Our data show that
vacuum-assisted core biopsy is more accurate
compared to not-vacuum-assisted core biopsy avoid-
ing false-negative results in low radiological risk
calcifications.
We cannot confirm a prevalence of columnar cell
lesions in women of younger age, as previously
suggested.24 In addition, the low number of indivi-
duals taking hormone replacement therapy cannot
allow any definitive conclusion on the relationship
of columnar cell lesions with hormone exposure;
however, an association with atypia and the length
of hormone replacement therapy could be assumed.
This hypothesis could have a rationale, considering
that columnar cells express high levels of estrogen
receptor but are low-proliferating cells.10 Because
estrogen stimulates proliferation24 and suppresses
apoptosis25 in normal cells, elevated estrogen re-
ceptor expression in columnar cell lesions may be a
fundamental alteration leading to hyperplasia that
occasionally progresses to atypia and cancer.26 In
Table 5 Histological correlations between stereotactic vacuum-assisted core biopsy and surgical excision in columnar cell lesions group






B2 CCL without atypia 68 5 (7%) – – 63 (93%)
B3 FEA 38 13 (34%) 20 (53%) – 5 (13%)
CCL without atypia and papilloma 1 – – – 1 (100%)
CCL without atypia or FEA with LIN 11 2 (18%) 5 (45%) 1 (9%) 3 (27%)
CCL without atypia or FEA with ADH 2 1 (50%) 1 (50%) – –
B4 Extensive FEA 3 1 (33%) 2 (67%) – –
B5 CCL without atypia and DCIS 4 – – 4 (100%) –
FEA and DCIS 9 – 1 (11%) 8 (89%) –
CCL without atypia with IC 1 – – 1 (100%) –
CCL: columnar cell lesions; FEA: flat epithelial atypia; LIN: lobular intraepithelial neoplasia; ADH: atypical ductal hyperplasia; DCIS: ductal
carcinoma in situ; IC: invasive carcinoma; FU: follow up.
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fact, columnar cell lesions are considered not
obligate precursors of lobular and tubular carcino-
mas,12,20–22 two cancer histotypes closely related to
hormone replacement therapy exposure.27 Interest-
ingly, the results of a recent experimental study
indicate that 17b-estradiol exposure of postmeno-
pausal primates promotes proliferation of flat
epithelial atypia.11
In conclusion, columnar cell lesions are never
associated with BI-RADS5 category and linear or
branching calcifications. Using specific histological
criteria for diagnosis of flat epithelial atypia on
stereotactic vacuum-assisted core biopsy specimens
and in agreement with other authors,15 we suggest
that (1) a multidisciplinary approach is essential for
management of columnar cell lesions; (2) surgery
has to be considered when columnar cell lesions
without atypia or flat epithelial atypia are associated
with other risk lesions, such as atypical ductal
hyperplasia or lobular intraepithelial neoplasia, on
vacuum-assisted core biopsy; and (3) an excision
biopsy is not mandatory only when histopathologi-
cal findings are concordant with the radiological
features and flat epithelial atypia is found on
stereotactic vacuum-assisted core biopsy as the most
advanced lesion. However, considering that flat
epithelial atypia is frequently multifocal and bilat-
eral,15 patients should be advised of the possible
hormonal dependency of this entity.
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